Via The Hill:
So the list price is almost $2000 in the United States. Why is it $8 in Australia?
Truvada still has patent protection in the United States, and in the rest of the world it’s generic. I can’t comment on the price in Australia of the generic medicines, but it is generically available in other parts of the world and will be generically available in the United States as of September and 2020, based upon Gilead agreeing to support generic entries one year early.
Thank you. So I think it’s important that we notice here that we, the public, we, the people, developed this drug, we paid for this drug, we led and developed all of the grounding patents to create PrEP, and then that patent has been privatized. Despite the fact that the patent is owned by the public, we refuse to enforce it. There’s no reason this should be $2000 a month. People are dying because of it, and there’s no enforceable reason for it. We own the core intellectual property for it, and, as a result, people are dying for no reason. For no reason.
When we talk about economics, there’s something known as a demand curve, with elasticity, and with every other commodity, you can say, “How much is this phone worth to you?” And you can say “$100,” “$200,” you can buy a Nokia phone, you can not have a phone at all. But you cannot ask the question, “How much will you pay to be alive?” “How much will you pay to live?” Because the answer is everything. The answer is, you will pay $10, you will pay $1000, you will go into debt, you will do anything to live. And that is what makes the price of medicine different than the price of an iPhone.